This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management of hypopharyngeal cancer

Authoring team

  • larynx-preserving treatment should be offered to people with locally-advanced squamous cell carcinoma of the hypopharynx if radiation and neo-adjuvant and/or concomitant chemotherapy would be suitable for them and they do not have:
    • tumour-related dysphagia needing a feeding tube
    • a compromised airway
    • recurrent aspiration pneumonias

  • radiotherapy with neo-adjuvant and/or concomitant chemotherapy should be offered if larynx-preserving treatment is suitable for the person

  • primary surgery followed by adjuvant radiotherapy should be offered to people if chemotherapy is not a suitable treatment for them

  • adjuvant radiotherapy should be offered to people having surgery as their primary treatment. Add concomitant chemotherapy if appropriate

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.